Alnylam Pharmaceuticals Inc (ALNY) Annual Income Statement (USD)
ALNY Quarterly Financials (USD)
Frequently Asked Questions About Alnylam Pharmaceuticals Inc (ALNY) Stock
Alnylam Pharmaceuticals Inc's (ALNY) last reported annual revenue was USD 1.83 Billion.
Alnylam Pharmaceuticals Inc's (ALNY) annual revenue growth rate based on the revenue reported in the past 5 years is : 89.45%
Alnylam Pharmaceuticals Inc's(ALNY) is not profitable as of its last reported annual financials.
The net profit margin for Alnylam Pharmaceuticals Inc's(ALNY) from its laster reported year is -24.08%
The return on equity (ROE) for Alnylam Pharmaceuticals Inc's(ALNY) from its last reported annual financials is : -1500.66%
The return on assets (ROA) for Alnylam Pharmaceuticals Inc's(ALNY) from its last reported annual financials is : -2.92%
The return on invested capital (ROIC) for Alnylam Pharmaceuticals Inc's(ALNY) from its last reported annual financials is : -34.83%
The Debt to Equity ratio for Alnylam Pharmaceuticals Inc's(ALNY) from its last reported annual financials is : -462.63%
The dividend yield for Alnylam Pharmaceuticals Inc's(ALNY) from its laster reported year is 0.00%
Alnylam Pharmaceuticals Inc's(ALNY) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ALNY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
